Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
We downgrade Nektar Therapeutics (NKTR) to Hold after the REZPEG/REZOLVE trial enrollment controversy and attendant class actions raise near-term regulatory and commercial uncertainty. The balance sheet and a still-high short-interest profile make the name tradeable on volatility, but the company’s valuation and cash burn demand caution. Our trade …
Spero Therapeutics, a clinical-stage biopharmaceutical company focused on immunology and inflammation, announced inducement grants totaling 556,000 equity awards (233,000 RSUs and 323,000 stock options) to new employees as part of the Nasdaq Listing Rule 5635(c)(4). These awards are intended as material inducements to attract new talent under the 2…
Pasqal, a Nasdaq-listed quantum computing firm, appointed Roger L. Chuchen as Head of Investor Relations to strengthen communication with investors and analysts as the company scales its commercial operations and expands its global customer base. Chuchen brings over 25 years of technology and investment experience, aiming to articulate Pasqal's lon…
WISeSat.Space Holdings Corp., a space technology company focused on secure satellite communications for IoT applications, completed its business combination with Columbus Acquisition Corporation and commenced trading on Nasdaq under the ticker SAIQ. As a subsidiary of WISeQey Corp., WISeSat.Space aims to expand satellite infrastructure integrating …
Aardvark Therapeutics, a clinical-stage biopharmaceutical company, announced an inducement grant of stock options to a new employee under Nasdaq Listing Rule 5635(c)(4). The grant consists of options for 60,000 shares of common stock at an exercise price of $5.27 per share, vesting over four years. This is part of the company's equity incentive pla…
PetMed Express, Inc. announced equity awards to two newly hired executives, CEO Jeff Willard and CTO Andrew Parry, as inducements to employment. The grants include restricted common stock and performance share units, which vest over three years and are tied to shareholder return performance relative to the S&P 600 Specialty Retail Index. These awar…
Rush Enterprises, Inc., the largest commercial vehicle dealership network in North America, is set to release its third quarter 2026 earnings after market close on October 27, 2026. The company will hold a conference call to discuss quarterly results on October 28, 2026.
Covenant Logistics Group, Inc. has scheduled its third quarter earnings release after market close on October 29, 2026, followed by a live conference call on October 30, 2026. The company provides a range of transportation and logistics services across the United States and is traded on the NYSE under the ticker CVLG.
Integer Holdings Corporation notifies holders that its 2.125% Convertible Senior Notes due 2028 are convertible between October 1, 2026, and December 31, 2026, following the stock price exceeding the conversion price threshold. Conversion may be in cash, shares, or a combination thereof.
WISeSat.Space, a subsidiary of WISeQey Corp., completed its business combination with Columbus Acquisition Corporation and began trading on Nasdaq under ticker symbol SAIQ. This marks WISeSat.Space as a publicly-listed company focused on post-quantum-secure satellite communications and IoT connectivity. The listing supports the company's mission to…
Carlsmed, a U.S. medical technology company specializing in AI-enabled personalized spine surgery solutions, announced inducement grants of stock options and restricted stock units to its newly appointed CFO and Chief Product and AI Officer as incentives for their employment. These grants were approved by the company’s independent Compensation Comm…
Alpha Teknova, Inc. (Nasdaq: TKNO) and Pluristyx, Inc. announced the completion of a Type II Drug Master File (DMF) submission for the PluriFreeze cryopreservation system to the FDA. This regulatory filing enables drug developers to incorporate PluriFreeze into their clinical and manufacturing workflows with documented FDA support, facilitating str…
MSC Industrial has delivered strong share-price performance this year, but the underlying valuation and margin profile leave little room for upside from current levels. We recommend a mid-term short targeting $110 with a hard stop at $137. The trade is predicated on near-term earnings risk, modest free cash flow relative to enterprise value, and a …
Horizon Bancorp, Inc., a Midwestern commercial bank holding company, announced it will review its third quarter 2026 financial results in a conference call on October 22, 2026. The company's earnings release will be published after market close on October 21, 2026. Horizon serves Indiana and Michigan with a focus on consumer and commercial banking,…
Natural Gas is trading at $3.037 on the 5-hour chart and is compressed between the 20-period and 50-period simple moving averages, while resting beneath the Ichimoku cloud. The market recently rebounded off the $2.966 Fibonacci support on rising volume. Short-term directional risk hinges on a breakout above the cloud around $3.06 or a breakdown bel…
Sea (SE) has retraced sharply from last year's highs and now shows a compelling buy-the-dip setup: strong top-line momentum (Q2 2026 revenue +48% to $7.8B), a softer valuation than at its peak, and oversold technicals (RSI ~30.6). This trade idea outlines a mid-term swing entry at $95.70, a stop at $86.00 to limit downside, and a target of $140.00 …
Gray Media, Inc., a leading multimedia company and the largest owner of top-rated local TV stations in the US, announced its third quarter 2026 earnings release will be published on November 6, 2026. The company will host a live conference call to discuss its operating results on the same day, providing investors with updates on financial performan…
GitLab's recent results and product shifts - notably Flex pricing and AI-driven feature demand - have accelerated ARR growth to 42% and produced clear upside in large customer deals. The business is trading at an attractive setup relative to sentiment but needs to prove margin stability. This trade idea presents a mid-term swing to capture continue…
Nvidia (NVDA) looks materially undervalued on a combination of free cash flow, return metrics and balance-sheet strength despite a lofty market cap. The trade is a long with a $234.465 entry, a $300 target and a $210 stop. Key risk: rising accounts receivable or slower-than-expected AI capex could erode free cash flow unexpectedly.
Remitly (RELY) looks like a high-quality growth fintech you can buy now: profitable, growing customers and cash flow, and trading below prior highs with room to rerate. This trade idea lays out entry, stop, targets, catalysts and risks for a long-term (46-180 trading days) position.
FMCB reported record quarterly profits, raised its dividend and expanded buybacks—metrics that support a constructive trade. The stock has run, but fundamentally-driven returns, solid capital and conservative lending give a favorable risk/reward for a long position over the next 180 trading days.
Intuitive Surgical’s share pullback looks like a buying opportunity. The robot-surgery leader still generates strong free cash flow ($3.22B last reported), trades at a premium but not absurd multiples versus growth prospects, and shows technicals consistent with a mean-reversion trade. Our plan: enter at $395.17, stop at $360.00, target $475.00 ove…
Accenture reported stronger-than-expected Q4 results driven by broad AI adoption and margin expansion. The combination of $18.7B quarterly revenue, a jump in operating margins to 15.3%, and management's FY2027 guidance plus aggressive capital allocation creates a near-term trade opportunity. I recommend initiating a long position on a dip with a $2…
Albemarle (ALB) has seen a large sentiment-driven drop, but key operating metrics - free cash flow of $1.34B, modest leverage, and ongoing capacity expansion - argue for a measured long. Technicals show oversold conditions while valuation metrics (EV/EBITDA ~8.7) leave room for re-rating. This trade plan uses a $104 entry, $95 stop, and $150 target…
Holley (HLLY) trades near its 52-week low but carries a free cash flow yield north of 15%, an EV/EBITDA of 6.7, and a sensible balance-sheet liquidity profile. Recent European expansion and core aftermarket durability make a long-biased, risk-defined trade attractive over the next 180 trading days even as economic conditions weaken.
